Degarelix Prescribing at VINE MEDICAL GROUP
Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression
Items (12m)
93
Total Quantity
108
NHS Cost
£12.8K
vs National Avg
+435.9%
VINE MEDICAL GROUP prescribed 93 items of Degarelix over the last 12 months at a cost of £12,763 to the NHS. This is 435.9% above the national average prescribing rate. Degarelix is classified under Sex hormones and hormone antagonists in malignant disease in the BNF.
Monthly Prescribing Trend
Jul 2026
6
Jul 2026
7
Jul 2026
8
Jul 2026
8
Jul 2026
7
Jul 2026
12
Jul 2026
6
Jul 2026
7
Jul 2026
7
Jul 2026
6
Jul 2026
10
Jul 2026
9
Prescribing Details
| Total Items | 93 |
|---|---|
| Total Quantity | 108 |
| Total NHS Cost | £12,763 |
| Presentations | 1 different forms |
| vs National Average | +435.9% |
Degarelix Prescribing Comparison
| This practice | 93 items |
|---|---|
| National average per practice | 17 items |
| Difference | +435.9% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.